Tellgen Corp (300642) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tellgen Corp (300642) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.19 Million ≈ $5.30 Million USD) by net assets (CN¥1.53 Billion ≈ $223.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tellgen Corp - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Tellgen Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300642 liabilities breakdown for a breakdown of total debt and financial obligations.
Tellgen Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tellgen Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Hongteo Accurate Technology Co Ltd
SHE:300176
|
0.066x |
|
Holtek Semiconductor Inc
TW:6202
|
0.034x |
|
PetroVietnam Transportation Corp
VN:PVT
|
0.081x |
|
Autocanada Inc
TO:ACQ
|
-0.095x |
|
PHX Energy Services Corporation
TO:PHX
|
0.090x |
|
VT Industrial Technology Co Ltd
SHE:300707
|
0.049x |
|
Vaibhav Global Limited
NSE:VAIBHAVGBL
|
0.047x |
|
Jilin Jlu Communication Design Institute Co Ltd
SHE:300597
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Tellgen Corp (2012–2024)
The table below shows the annual cash flow conversion efficiency of Tellgen Corp from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 300642 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.52 Billion ≈ $222.14 Million |
CN¥164.62 Million ≈ $24.09 Million |
0.108x | +31.75% |
| 2023-12-31 | CN¥1.54 Billion ≈ $224.72 Million |
CN¥126.40 Million ≈ $18.50 Million |
0.082x | -26.01% |
| 2022-12-31 | CN¥1.48 Billion ≈ $216.67 Million |
CN¥164.72 Million ≈ $24.10 Million |
0.111x | +88.02% |
| 2021-12-31 | CN¥1.40 Billion ≈ $204.32 Million |
CN¥82.61 Million ≈ $12.09 Million |
0.059x | -22.61% |
| 2020-12-31 | CN¥1.27 Billion ≈ $185.34 Million |
CN¥96.83 Million ≈ $14.17 Million |
0.076x | -48.90% |
| 2019-12-31 | CN¥1.17 Billion ≈ $171.01 Million |
CN¥174.84 Million ≈ $25.59 Million |
0.150x | -5.02% |
| 2018-12-31 | CN¥1.02 Billion ≈ $149.87 Million |
CN¥161.32 Million ≈ $23.61 Million |
0.158x | +33.13% |
| 2017-12-31 | CN¥895.86 Million ≈ $131.09 Million |
CN¥106.00 Million ≈ $15.51 Million |
0.118x | -65.30% |
| 2016-12-31 | CN¥288.65 Million ≈ $42.24 Million |
CN¥98.42 Million ≈ $14.40 Million |
0.341x | +1.41% |
| 2015-12-31 | CN¥192.33 Million ≈ $28.14 Million |
CN¥64.67 Million ≈ $9.46 Million |
0.336x | +7.97% |
| 2014-12-31 | CN¥131.05 Million ≈ $19.18 Million |
CN¥40.81 Million ≈ $5.97 Million |
0.311x | +12.41% |
| 2013-12-31 | CN¥95.04 Million ≈ $13.91 Million |
CN¥26.33 Million ≈ $3.85 Million |
0.277x | +193.02% |
| 2012-12-31 | CN¥72.47 Million ≈ $10.60 Million |
CN¥6.85 Million ≈ $1.00 Million |
0.095x | -- |
About Tellgen Corp
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in… Read more